Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.
Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y.
Okabayashi K, et al. Among authors: kitagawa y.
Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x. Epub 2012 Jul 16.
Cancer Sci. 2012.
PMID: 22676270
Free PMC article.